How does AIM benefit my
hospital?

Play Video

Benefits of AIM

Respiratory depression and hypoxia are the leading causes of patient injuries under sedation
AIM delivers higher oxygen concentration
Pharyngeal capnography makes AIM a reliable breathing monitor. Early alert leads to an early response, preventing hypoxic events
Access to the open oral cavity facilitates placement of airway devices, without excessive jaw manipulation in sedated, hypoxic and fragile patients. Rushed emergency maneuvers lead to injuries
Pharyngeal oxygen delivery may lower the risk of airway fires leading to patient injuries and lawsuits

AIM offers an improved method of oxygen delivery by lowering the dead space, resulting in a higher FiO₂ while utilizing significantly less oxygen than the commonly used devices. This feature could be of additional value in situations where oxygen conservation is essential

In the absence of safer options, anesthesia providers often default to general anesthesia for complex cases, adding costs, longer OR and recovery times
AIM safety features provide with the confidence to choose sedation over general anesthesia, in suitable cases
High-flow nasal cannula is often used for complex cases but the main device and disposables can be expensive to acquire, maintain and store. It does not monitor breathing and is not MRI compatible, the setup takes time and requires electricity to operate.
AIM is less expensive, maintenance-free, and monitors breathing. It is MRI compatible and does not require a setup or electricity to operate.

AIM replaces face masks and bite-blocks strapped around a patient’s neck, and can reduce anxiety in patients who are claustrophobic and those who don’t tolerate face mask placement.

With increased safety and versatility AIM could help with the logistical challenges faced by the hospitals while dealing with multiple vendors, stocking of multiple devices, product availability and the price changes

With a much smaller surface area and compact form, compared to the face masks and the high-oxygen flow devices, the AIM device consumes fewer manufacturing resources and raw materials. Additionally, by eliminating the need for endoscopy and TEE bite-blocks and awake fiberoptic-intubation airways, AIM further lowers the environmental impact by reducing the number of contaminated disposables, otherwise required for OR and NORA procedures.